Clinical Trial Update: Velcade in MALT Lymphoma Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Velcade (bortezomib) in patients with MALT lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malt Lymphoma

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: Medical University of Vienna | Conditions: MALT Lymphoma | Phase 2 | Status: COMPLETED